Real-world data on antiviral treatments for hepatitis C virus infections: Can we define intention to treat or per protocol analyses?

J Hepatol. 2018 Aug;69(2):551-553. doi: 10.1016/j.jhep.2018.02.037. Epub 2018 May 26.

Authors

Rohit P Ojha¹, Ewout W Steyerberg²

Affiliations

¹ Center for Outcomes Research, JPS Health Network, Fort Worth, TX, USA; Department of Biostatistics and Epidemiology, School of Public Health, UNT Health Science Center, Fort Worth, TX, USA. Electronic address: rojha@jpshealth.org.
² Department of Public Health, Erasmus Medical Center, Rotterdam, Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands.

PMID: 29843905
DOI: 10.1016/j.jhep.2018.02.037

No abstract available

Keywords: Direct-acting antivirals; Hepatitis C virus; Intention to treat; Observational; Per protocol; Real-world.

Publication types

Letter
Comment

MeSH terms

Antiviral Agents*
Benzimidazoles
Fluorenes
Hepacivirus
Hepatitis C, Chronic*
Humans
Intention to Treat Analysis
Sofosbuvir

Substances

Antiviral Agents
Benzimidazoles
Fluorenes
ledipasvir
Sofosbuvir